|
|
Lftd Partners Inc
LIFD's Fundamental analysis
|
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
|
Lftd Partners Inc 's sales fell
by -33.68 % in III. Quarter 2024 from the same quarter a year ago.
Ranking at No. 1557
Major Pharmaceutical Preparations industry recorded
growth of revenues by 9.75 %
Lftd Partners Inc faced net loss in contrast to the net income a year ago in III. Quarter 2024
• More on LIFD's Growth
|
|
Lftd Partners Inc
realized a net loss in trailing twelve months.
Company is currently trading with Price to Cash flow multiple of 4.2 in trailing twelve-month period. |
| Company |
| - |
|
PE TTM
|
| Industry |
|
- |
|
PE TTM
|
|
Company's Price to Sales ratio is at 0.11.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.42.
• More on LIFD's Valuation
|
|
|
|
|
Lftd Partners Inc
realized net loss in trailing twelve months.
Company is currently trading with Price to Cash flow multiple of 4.2 in trailing twelve-month period. |
| Company |
| - |
|
PE TTM
|
| Industry |
|
- |
|
PE TTM
|
|
Company's Price to Sales ratio is at 0.11.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.42.
Lftd Partners Inc Price to Book Ratio is at 0.12 lower than Industry Avg. of 82.31. and higher than S&P 500 Avg. of 0.02
• More on LIFD's Valuation
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
